Formic Acid

Formic Acid

SCHEMBL29537715

C=C(C(N)=O)c1ccc(Nc2ncc3c(n2)N2CCN=C2C(Oc2ccc(F)cc2F)=C3)cc1.O=CO

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MAPK8 P45983 2/20 0.38
▸ STAT6 P42226 5/20 0.36
▸ JAK3 P52333 3/20 0.35
▸ CCNT1 O60563 1/20 0.34
▸ CCNE1 P24864 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ CDK9 P50750 1/20 0.34
▸ LCK P06239 4/20 0.33
▸ EGFR P00533 2/20 0.33
▸ CDK4 P11802 1/20 0.33
▸ CCND1 P24385 1/20 0.33
▸ AURKA O14965 2/20 0.33
▸ JAK2 O60674 1/20 0.33
▸ AURKB Q96GD4 1/20 0.33
▸ SCN9A Q15858 1/20 0.33
▸ BTK Q06187 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL25423226 1.00 MAPK8 (0.38) MAPK8STAT6JAK3CCNT1CCNE1
Formic Acid SCHEMBL25423830 0.92 SCN9A (0.39) CCNT1CCNE1CDK2CDK9EGFR
Formic Acid SCHEMBL29536657 0.92 SCN9A (0.39) CCNT1CCNE1CDK2CDK9EGFR
Formic Acid SCHEMBL30595871 0.87 EGFR (0.43) JAK3CDK2EGFRBTK
SCHEMBL30595902 0.85 MAPK8 (0.41) MAPK8JAK3CCNT1CCNE1CDK2
SCHEMBL26075404 0.85 MAPK8 (0.41) MAPK8JAK3CCNT1CCNE1CDK2
SCHEMBL26076556 0.84 EGFR (0.45) JAK3CDK2EGFRBTK
SCHEMBL30590717 0.84 EGFR (0.45) JAK3CDK2EGFRBTK
Formic Acid SCHEMBL30595851 0.82 EGFR (0.48) JAK3EGFRBTK
SCHEMBL30590720 0.80 EGFR (0.50) JAK3EGFRBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4192582-A1 KINASE INHIBITORS AND USES THEREOF ABM Therapeutics Corporation (US) 2023-06-14 — — EP disclosed
WO-2022032071-A1 KINASE INHIBITORS AND USES THEREOF ABM THERAPEUTICS CORPORATION (US) 2022-02-10 — — WO disclosed
Send feedback